KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Operations (2016 - 2025)

Zimmer Biomet Holdings has reported Cash from Operations over the past 17 years, most recently at 517400000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 517400000.0 for Q4 2025, up 2.19% from a year ago — trailing twelve months through Dec 2025 was 1697100000.0 (up 13.19% YoY), and the annual figure for FY2025 was 1697100000.0, up 13.19%.
  • Cash from Operations for Q4 2025 was 517400000.0 at Zimmer Biomet Holdings, up from 418700000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for ZBH hit a ceiling of 588400000.0 in Q4 2023 and a floor of 223500000.0 in Q1 2021.
  • Median Cash from Operations over the past 5 years was 373800000.0 (2024), compared with a mean of 376930000.0.
  • Peak annual rise in Cash from Operations hit 893.56% in 2021, while the deepest fall reached 50.43% in 2021.
  • Zimmer Biomet Holdings' Cash from Operations stood at 337600000.0 in 2021, then decreased by 27.67% to 244200000.0 in 2022, then soared by 140.95% to 588400000.0 in 2023, then dropped by 13.95% to 506300000.0 in 2024, then grew by 2.19% to 517400000.0 in 2025.
  • The last three reported values for Cash from Operations were 517400000.0 (Q4 2025), 418700000.0 (Q3 2025), and 378200000.0 (Q2 2025) per Business Quant data.